perhexiline has been researched along with glutamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bhuiyan, H; Broom, OJ; Islam, S; Lehtiö, J; Lindahl, A; Linnarsson, S; Nordström, A; Stäubert, C; Zhu, Y | 1 |
1 review(s) available for perhexiline and glutamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for perhexiline and glutamine
| Article | Year |
|---|---|
Rewired metabolism in drug-resistant leukemia cells: a metabolic switch hallmarked by reduced dependence on exogenous glutamine.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Acetyl-CoA C-Acyltransferase; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbon-Carbon Double Bond Isomerases; Cell Line, Tumor; Cyclosporins; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Enoyl-CoA Hydratase; Fatty Acids; Glutamine; Glycolysis; Humans; Leukemia; Metabolome; Oxidation-Reduction; Pantothenic Acid; Perhexiline; Racemases and Epimerases; RNA, Messenger; Transcriptome | 2015 |